Paragon Capital Management LLC Johnson & Johnson Transaction History

Paragon Capital Management LLC

$183 Million
Q3 2024

A detailed history of Paragon Capital Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Paragon Capital Management LLC holds 32,524 shares of JNJ stock, worth $5.05 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares

32,524

Previous 33,036 1.55%

Holding current value

$5.05 Million

Previous $4.83 Million 9.15%

% of portfolio

2.88%

Previous 2.73%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$145.48 - $167.38 $74,485 - $85,698	-512 Reduced 1.55%	32,524 $5.27 Million
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $120,268 - $131,430	-833 Reduced 2.46%	33,036 $4.83 Million
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $39,115 - $41,010	252 Added 0.75%	33,869 $5.36 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $113,568 - $123,926	-780 Reduced 2.27%	33,617 $5.27 Million
Q3 2023 Nov 08, 2023	SELL	$155.75 - $174.48 $690,128 - $773,120	-4,431 Reduced 11.41%	34,397 $5.36 Million
Q2 2023 Aug 08, 2023	SELL	$154.35 - $166.11 $72,081 - $77,573	-467 Reduced 1.19%	38,828 $6.43 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $82,171 - $98,061	-544 Reduced 1.37%	39,295 $6.09 Million
Q4 2022 Feb 08, 2023	SELL	$160.2 - $179.79 $20,505 - $23,013	-128 Reduced 0.32%	39,839 $7.04 Million
Q3 2022 Nov 08, 2022	SELL	$161.33 - $179.52 $89,376 - $99,454	-554 Reduced 1.37%	39,967 $6.53 Million
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $80,226 - $88,726	-477 Reduced 1.16%	40,521 $7.19 Million
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $76,381 - $86,741	-483 Reduced 1.16%	40,998 $7.27 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $280,050 - $310,725	-1,796 Reduced 4.15%	41,481 $7.1 Million
Q3 2021 Nov 10, 2021	SELL	$161.5 - $179.47 $93,347 - $103,733	-578 Reduced 1.32%	43,277 $6.99 Million
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $129,338 - $138,737	-811 Reduced 1.82%	43,855 $7.23 Million
Q1 2021 Apr 30, 2021	SELL	$153.07 - $170.48 $230,829 - $257,083	-1,508 Reduced 3.27%	44,666 $7.39 Million
Q4 2020 Jan 21, 2021	SELL	$137.11 - $157.38 $137,384 - $157,694	-1,002 Reduced 2.12%	46,174 $7.27 Million
Q3 2020 Oct 21, 2020	SELL	$140.38 - $153.83 $63,030 - $69,069	-449 Reduced 0.94%	47,176 $7.02 Million
Q2 2020 Aug 03, 2020	BUY	$128.81 - $155.51 $32,588 - $39,344	253 Added 0.53%	47,625 $6.7 Million
Q1 2020 May 01, 2020	SELL	$111.14 - $153.99 $199,385 - $276,258	-1,794 Reduced 3.65%	47,372 $6.21 Million
Q4 2019 Feb 03, 2020	SELL	$127.5 - $146.44 $253,470 - $291,122	-1,988 Reduced 3.89%	49,166 $7.17 Million
Q3 2019 Oct 31, 2019	SELL	$126.95 - $142.14 $1.07 Million - $1.19 Million	-8,407 Reduced 14.11%	51,154 $6.62 Million
Q2 2019 Aug 06, 2019	BUY	$131.15 - $144.24 $189,905 - $208,859	1,448 Added 2.49%	59,561 $8.3 Million
Q1 2019 Apr 15, 2019	BUY	$125.72 - $139.79 $2,514 - $2,795	20 Added 0.03%	58,113 $8.12 Million
Q4 2018 Jan 18, 2019	SELL	$122.84 - $147.84 $746,621 - $898,571	-6,078 Reduced 9.47%	58,093 $7.5 Million
Q3 2018 Nov 08, 2018	BUY	$121.58 - $142.88 $7.49 Million - $8.81 Million	61,635 Added 2430.4%	64,171 $0
Q2 2018 Aug 01, 2018	SELL	$119.4 - $131.76 $10 Million - $11.1 Million	-84,150 Reduced 97.07%	2,536 $269,000
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $206,415 - $244,430	-1,650 Reduced 1.87%	86,686 $11.1 Million
Q4 2017 Feb 16, 2018	SELL	$131.22 - $143.62 $1.09 Million - $1.19 Million	-8,316 Reduced 8.6%	88,336 $12.3 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $12.5 Million - $13.1 Million	96,652	96,652 $12.6 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LLC with notifications on news.

Account

Paragon Capital Management LLC Johnson & Johnson Transaction History